Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
And look at who has the advanced plasma graphene vessel at the Manchester graphene centre, it is Haydale
Great list but there are others, two I remember are Chinese partnership Dalian Yibang (lightning conductors for wind turbines, planes and other new uses; industrial filtration)
- wearable graphene enhanced garments for ultra athletes (Olympics 2021 contract)
Results with recent sales figures next week. I’m not even that bothered about the masks, some of these other pies were thrown in early to mid 2020 and they take a while to bake. There are so many of them. I don’t need ALL these horses to come home !
Confound Siemens and their H2 electrolyser. Also AFC and progressive energy's £750m announced today, again a rival (non-ITM) green hydrogen electrolysis investment. Confound Essar too (today's news, all three). News also on TP Group...firms are looking at buying its marine electrolyser (makes H2 and O2) ???
Actually I kept some so I win either way. But I didn't speak of a French trial. I said French emergency use approval, from 15th October, which was much written about on here in the fortnight leading up to that (there was hope of the same on an EU level).
It's a real thing that happened, but we don't yet receive news of happy French people saved by the interferon, which I have long hoped for. You need to read the forum more regularly.
Drat, it was symvastatin, I was watching just now. By and by, Synairgen will be newsworthy again. Certainly if the trial works out or we suddenly get news from France (is it only me that remembers the french emergency approval).
It's as if I read a different RNS to everyone else. The home trial in summer, which I thought seemed remarkable, and would certainly have applied for (I mean, it was FREE) had I had a bad enough but non-hospitalised case of Covid to warrant it, had hardly any takers, and effectively is only going to really start now, 5 months later than we all thought that it had. Everything is is just about the start of the £80m trial process that we all knew would start about now in USA and UK; there are one or two encouraging signs about that though. Still nothing whatsoever about the emergency-approved trial in France that started 15th October, and I was hoping for some good stories or data coming out of that. Is that a dud start too, like the home use self-enrolment (if suitable) trial ? Anyway I had topped up recently at 92p hoping for an uptick on news (it tends to over-react to news positively, like that previous recent uptick to 125.5p), and sold most at 140 today, so I'm happy as Larry, because I believe it will now fall and I'll get back in cheaper. You don't need to all pile in and abuse me for that; if you're sure I'm wrong, hold, and enjoy the thought that I sold most of my shares today should it rise more. Share chat rooms should welcome diversity of opinion, and challenges to groupthink.
Mr Tang got baricitinib, not Synairgen. It only reduces duration by one day and has risk of TB, may exacerbate fungal lung infections, is associated with lymphoma and other malignancies plus can cause UTIs. No idea at what probabilities. It's been used for arthritis and dermatitis. It doesn't sound as good as Synairgen. Why don't we hear of the French emergency use approved 15th October ... is it being used much ? Miraculous results, or not so good ? I'd love to know
Sorry, is same link, I searched on Australia and Friel and for some reason Yahoo didn't find it so I thought it wasn't there (did also skim, but obviously badly !!)
Correct link :
https://uk.finance.yahoo.com/news/the-uk-launches-worlds-first-human-challenge-trial-for-covid-19-with-irish-company-h-vivo-063000119.html - the quotation is true, and is very interesting and positive.
Cathal Friel, hVivo’s executive chairperson, told Yahoo Finance that in addition to the U.K. launch, the company is also in final stages for establishing a quarantine center in Australia, and “shortly thereafter, in North America.” But where on the continent has yet to be revealed. In both cases, hVivo would be partnering, rather than running, the trials.
Whilst that is excellent news, I cannot find it on the link you provided. Not a word there about Belgium, Australia or USA, nor a quote from Mrs Friel
The equivalent (ish) to ODX (at least as far as vaccine manufacture, which for both is only part of their substantial businesses) overseas is biontech, who will make the Pfizer vaccine. USA listed. Has gone up 10% recently, their chat room suggests some perceive vaccine making as the reason for the rise. ODX is due that sort of rise soon, as we move closer to making vaccines; last week's unrelated-to-vaccines RNS wasn't bad either. To the poster who totally randomly mentioned COG - I follow that and have read its recent RNSs, it did rise last week then fell back; it's (a) cr@p, it has nothing prompt to come, (b) not ODX, so don't waste bandwidth mentioning it here. It has its own board - go there.
What happened to terpentech's nit treatment for the back to school last month ? They previously promised it for back to school September 2018, or was it 2019. Then the following January. Then in the FAQ's on line for the June AGM, we were told terpentech's nit treatment was due for the back to school last month, September. At a budget GB supermarket. What happened ? The shelf life issue even at 50 degrees was proven even after a year to not be an issue. It all seemed set fair. Why do we never actually sell anything ??
Mevalone approved in france Feb 2017, or was it 2018. Can't recall. Why not decent sales by now if it's good stuff, or are farmers that reactionary that they take a decade to use new stuff ?
I meant to say, we will eventually use both our sites at full capacity I am sure for various tests. I kept half my ODX and will buy back the other half near end of month cheaper, if my plan works out. I suspect sag possible short term unless something happens
I sold today in order to add Synairgen cheaply. Sales update ODX is end month, RTC starts in volume being made only once the Icelandic machine is user acceptance tested and then disassembled, shipped to either Livingstone or Littleport and reassembled and commissioned. Meantime it would help if Avacta's spit test was approved, as we know ODX have at least spoken to them although our CEO played that down so it may not have been much. If it is approved, perhaps we might make it. The big money is always for the patent holder, not the manufacturer, but that's fair reward for the R&D to design the test. We will eventually use both our sites I
Na, all Labour do is say the government is "failing", it's starmer's main phrase. Someone has told him to repeat it endlessly. When Starmer is trying to sound statesmanlike, he sounds such a complete idiot and bluffer !! Like a teenager trying to sound earnest, authoritative and clever. At least Boris is sort of engaging and charismatic.
Taiwan is so badly treated. An independent democratic country that nobody can name or acknowledge as such, and which in the olympics had to be referred to ridiculously as "Taipei" to please a fascist country that's touchy about it. Not communist; it has a stock market and the biggest disparity of wealth in the world (ask Jack Ma). Fascist .
We should acknowledge the republic of china on Taiwan as a proper country with full diplomatic rights. The world health authority expelled it last year and stopped sending it health circulars because said fascist country told them to. Outrageous.
I think the risk/reward is better on JOG than HUR right now. Hurricane, we know too much now and it's all bad. JOG, has slumped so far purely on news void; it's like HUR was when she was 22p, and jumped to 38 then 62 then 33p. JOG has everything to prove and develop up, and no reason at present for pessimism as it's a good formation.